HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacodynamics and pharmacokinetics of khat: a controlled study.

AbstractOBJECTIVES:
To show the subjective and cardiovascular effects of khat leaves having a standardized content of cathinone.
BACKGROUND:
The main effect of khat is an increase of energy and alertness. This effect is thought to be attributable to the phenylalkylamine cathinone, but no controlled clinical trials have been published.
DESIGN:
The design was balanced and double blind. Six drug-naïve volunteers received a single dose of khat corresponding to 0.8 mg/kg body weight, as well as alkaloid-free khat as a placebo. Psychologic effects were evaluated by the Addiction Research Center Inventory (ARCI) and visual analog scales. Physiologic measures were systolic blood pressure, diastolic blood pressure, and heart rate. Plasma concentrations of cathinone and its metabolites norephedrine and R,R-(-)norpseudoephedrine were determined by HPLC.
RESULTS:
Maximal plasma concentrations of cathinone (127 +/- 53 [SD] ng/ml) were attained after 127 +/- 30 minutes. The area under the plasma concentration-time curve from 0 to 9 hours was 415 +/- 207 ng/ml.hr, and the terminal elimination half-life was 260 +/- 102 minutes. An effect of khat was observed in the ARCI scales Abuse Potential (p < 0.01), Motor Stimulation (p < 0.02), Amphetamine-Like Effect (p < 0.005), and Stimulation-Euphoria (p < 0.005), as well as in the visual analog scales Excited-Calm (p < 0.001) and Energetic-Lethargic (p < 0.001).
CONCLUSIONS:
Our results provide objective evidence for the amphetamine-like stimulatory effects of khat leaves. These effects were closely similar to those observed after cathinone, 0.5 mg/kg body weight, although peak plasma concentrations of cathinone after khat were delayed.
AuthorsP Widler, K Mathys, R Brenneisen, P Kalix, H U Fisch
JournalClinical pharmacology and therapeutics (Clin Pharmacol Ther) Vol. 55 Issue 5 Pg. 556-62 (May 1994) ISSN: 0009-9236 [Print] United States
PMID7910126 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Alkaloids
  • Central Nervous System Stimulants
  • Plant Extracts
  • Psychotropic Drugs
  • cathinone
Topics
  • Adult
  • Affect (drug effects)
  • Alkaloids (pharmacology)
  • Blood Pressure (drug effects)
  • Cardiovascular System (drug effects)
  • Catha
  • Central Nervous System Stimulants (pharmacology)
  • Double-Blind Method
  • Heart Rate (drug effects)
  • Humans
  • Male
  • Plant Extracts (pharmacology)
  • Psychotropic Drugs (pharmacology)
  • Reference Values

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: